Global Human Serum and Plasma Industry Growth and Trends Forecast to 2031

Summary

According to APO Research, The global Human Serum and Plasma market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Human Serum and Plasma is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Human Serum and Plasma is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Human Serum and Plasma is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Human Serum and Plasma include Thermo Fisher, Merck Millipore, Baxter, Zen-Bio, Trina Bioreactives, TCS Biosciences Ltd, SeraCare, Monobind and Cytiva, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Serum and Plasma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Serum and Plasma.
The Human Serum and Plasma market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Serum and Plasma market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Human Serum and Plasma Segment by Company

Thermo Fisher
Merck Millipore
Baxter
Zen-Bio
Trina Bioreactives
TCS Biosciences Ltd
SeraCare
Monobind
Cytiva
Akron
Human Serum and Plasma Segment by Type

Fresh Human Serum and Plasma
Frozen Human Serum and Plasma
Human Serum and Plasma Segment by Application

Vaccines and Antibodies
Cell Culture
In Vitro Diagnostics
Clinical Research
Others
Human Serum and Plasma Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Serum and Plasma market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Human Serum and Plasma and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Serum and Plasma.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Serum and Plasma manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Human Serum and Plasma in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Human Serum and Plasma Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Human Serum and Plasma Sales Estimates and Forecasts (2020-2031)
1.3 Human Serum and Plasma Market by Type
1.3.1 Fresh Human Serum and Plasma
1.3.2 Frozen Human Serum and Plasma
1.4 Global Human Serum and Plasma Market Size by Type
1.4.1 Global Human Serum and Plasma Market Size Overview by Type (2020-2031)
1.4.2 Global Human Serum and Plasma Historic Market Size Review by Type (2020-2025)
1.4.3 Global Human Serum and Plasma Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Human Serum and Plasma Sales Breakdown by Type (2020-2025)
1.5.2 Europe Human Serum and Plasma Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Human Serum and Plasma Sales Breakdown by Type (2020-2025)
1.5.4 South America Human Serum and Plasma Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Human Serum and Plasma Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Human Serum and Plasma Industry Trends
2.2 Human Serum and Plasma Industry Drivers
2.3 Human Serum and Plasma Industry Opportunities and Challenges
2.4 Human Serum and Plasma Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Human Serum and Plasma Revenue (2020-2025)
3.2 Global Top Players by Human Serum and Plasma Sales (2020-2025)
3.3 Global Top Players by Human Serum and Plasma Price (2020-2025)
3.4 Global Human Serum and Plasma Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Human Serum and Plasma Major Company Production Sites & Headquarters
3.6 Global Human Serum and Plasma Company, Product Type & Application
3.7 Global Human Serum and Plasma Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Human Serum and Plasma Market CR5 and HHI
3.8.2 Global Top 5 and 10 Human Serum and Plasma Players Market Share by Revenue in 2024
3.8.3 2023 Human Serum and Plasma Tier 1, Tier 2, and Tier 3
4 Human Serum and Plasma Regional Status and Outlook
4.1 Global Human Serum and Plasma Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Human Serum and Plasma Historic Market Size by Region
4.2.1 Global Human Serum and Plasma Sales in Volume by Region (2020-2025)
4.2.2 Global Human Serum and Plasma Sales in Value by Region (2020-2025)
4.2.3 Global Human Serum and Plasma Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Human Serum and Plasma Forecasted Market Size by Region
4.3.1 Global Human Serum and Plasma Sales in Volume by Region (2026-2031)
4.3.2 Global Human Serum and Plasma Sales in Value by Region (2026-2031)
4.3.3 Global Human Serum and Plasma Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Human Serum and Plasma by Application
5.1 Human Serum and Plasma Market by Application
5.1.1 Vaccines and Antibodies
5.1.2 Cell Culture
5.1.3 In Vitro Diagnostics
5.1.4 Clinical Research
5.1.5 Others
5.2 Global Human Serum and Plasma Market Size by Application
5.2.1 Global Human Serum and Plasma Market Size Overview by Application (2020-2031)
5.2.2 Global Human Serum and Plasma Historic Market Size Review by Application (2020-2025)
5.2.3 Global Human Serum and Plasma Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Human Serum and Plasma Sales Breakdown by Application (2020-2025)
5.3.2 Europe Human Serum and Plasma Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Human Serum and Plasma Sales Breakdown by Application (2020-2025)
5.3.4 South America Human Serum and Plasma Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Human Serum and Plasma Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Thermo Fisher
6.1.1 Thermo Fisher Comapny Information
6.1.2 Thermo Fisher Business Overview
6.1.3 Thermo Fisher Human Serum and Plasma Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Thermo Fisher Human Serum and Plasma Product Portfolio
6.1.5 Thermo Fisher Recent Developments
6.2 Merck Millipore
6.2.1 Merck Millipore Comapny Information
6.2.2 Merck Millipore Business Overview
6.2.3 Merck Millipore Human Serum and Plasma Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck Millipore Human Serum and Plasma Product Portfolio
6.2.5 Merck Millipore Recent Developments
6.3 Baxter
6.3.1 Baxter Comapny Information
6.3.2 Baxter Business Overview
6.3.3 Baxter Human Serum and Plasma Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Baxter Human Serum and Plasma Product Portfolio
6.3.5 Baxter Recent Developments
6.4 Zen-Bio
6.4.1 Zen-Bio Comapny Information
6.4.2 Zen-Bio Business Overview
6.4.3 Zen-Bio Human Serum and Plasma Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Zen-Bio Human Serum and Plasma Product Portfolio
6.4.5 Zen-Bio Recent Developments
6.5 Trina Bioreactives
6.5.1 Trina Bioreactives Comapny Information
6.5.2 Trina Bioreactives Business Overview
6.5.3 Trina Bioreactives Human Serum and Plasma Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Trina Bioreactives Human Serum and Plasma Product Portfolio
6.5.5 Trina Bioreactives Recent Developments
6.6 TCS Biosciences Ltd
6.6.1 TCS Biosciences Ltd Comapny Information
6.6.2 TCS Biosciences Ltd Business Overview
6.6.3 TCS Biosciences Ltd Human Serum and Plasma Sales, Revenue and Gross Margin (2020-2025)
6.6.4 TCS Biosciences Ltd Human Serum and Plasma Product Portfolio
6.6.5 TCS Biosciences Ltd Recent Developments
6.7 SeraCare
6.7.1 SeraCare Comapny Information
6.7.2 SeraCare Business Overview
6.7.3 SeraCare Human Serum and Plasma Sales, Revenue and Gross Margin (2020-2025)
6.7.4 SeraCare Human Serum and Plasma Product Portfolio
6.7.5 SeraCare Recent Developments
6.8 Monobind
6.8.1 Monobind Comapny Information
6.8.2 Monobind Business Overview
6.8.3 Monobind Human Serum and Plasma Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Monobind Human Serum and Plasma Product Portfolio
6.8.5 Monobind Recent Developments
6.9 Cytiva
6.9.1 Cytiva Comapny Information
6.9.2 Cytiva Business Overview
6.9.3 Cytiva Human Serum and Plasma Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cytiva Human Serum and Plasma Product Portfolio
6.9.5 Cytiva Recent Developments
6.10 Akron
6.10.1 Akron Comapny Information
6.10.2 Akron Business Overview
6.10.3 Akron Human Serum and Plasma Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Akron Human Serum and Plasma Product Portfolio
6.10.5 Akron Recent Developments
7 North America by Country
7.1 North America Human Serum and Plasma Sales by Country
7.1.1 North America Human Serum and Plasma Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Human Serum and Plasma Sales by Country (2020-2025)
7.1.3 North America Human Serum and Plasma Sales Forecast by Country (2026-2031)
7.2 North America Human Serum and Plasma Market Size by Country
7.2.1 North America Human Serum and Plasma Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Human Serum and Plasma Market Size by Country (2020-2025)
7.2.3 North America Human Serum and Plasma Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Human Serum and Plasma Sales by Country
8.1.1 Europe Human Serum and Plasma Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Human Serum and Plasma Sales by Country (2020-2025)
8.1.3 Europe Human Serum and Plasma Sales Forecast by Country (2026-2031)
8.2 Europe Human Serum and Plasma Market Size by Country
8.2.1 Europe Human Serum and Plasma Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Human Serum and Plasma Market Size by Country (2020-2025)
8.2.3 Europe Human Serum and Plasma Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Human Serum and Plasma Sales by Country
9.1.1 Asia-Pacific Human Serum and Plasma Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Human Serum and Plasma Sales by Country (2020-2025)
9.1.3 Asia-Pacific Human Serum and Plasma Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Human Serum and Plasma Market Size by Country
9.2.1 Asia-Pacific Human Serum and Plasma Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Human Serum and Plasma Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Human Serum and Plasma Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Human Serum and Plasma Sales by Country
10.1.1 South America Human Serum and Plasma Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Human Serum and Plasma Sales by Country (2020-2025)
10.1.3 South America Human Serum and Plasma Sales Forecast by Country (2026-2031)
10.2 South America Human Serum and Plasma Market Size by Country
10.2.1 South America Human Serum and Plasma Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Human Serum and Plasma Market Size by Country (2020-2025)
10.2.3 South America Human Serum and Plasma Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Human Serum and Plasma Sales by Country
11.1.1 Middle East and Africa Human Serum and Plasma Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Human Serum and Plasma Sales by Country (2020-2025)
11.1.3 Middle East and Africa Human Serum and Plasma Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Human Serum and Plasma Market Size by Country
11.2.1 Middle East and Africa Human Serum and Plasma Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Human Serum and Plasma Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Human Serum and Plasma Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Human Serum and Plasma Value Chain Analysis
12.1.1 Human Serum and Plasma Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Human Serum and Plasma Production Mode & Process
12.2 Human Serum and Plasma Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Human Serum and Plasma Distributors
12.2.3 Human Serum and Plasma Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings